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THE addition of copper salts to a diet containing a carcinogenic azo dye affords
a degree of protection against hepatocarcinogenesis to rats consuming the diet
(Howell, 1958). It has also been found that rats which are fed 3'-methyl-4-
dimethylaminoazobenzene (Neish, 1959b) or which receive single intraperitoneal
injections of various hepatocarcinogens (Neish, 1958, 1959a) suffer a marked
decline in the serum levels of total copper and of the copper-containing enzyme
para-phenylenediamine oxidase (caeruloplasmin). The degree and persistence
of this decline appear to be correlated closely with the carcinogenic potency of
the injected materials. These results suggest that a derangement of copper
metabolism in rat livers may occur at an early stage in hepatocarcinogenesis.
Serum levels of total copper and caeruloplasmin are generally subnormal in
patients with hepatolenticular degeneration (Scheinberg and Sternlieb, 1959)
and Uzman (1957) and Uzman et al. (1956) have detected an abnormal copper-avid
ninhydrin-reacting substance, possibly a peptide, in the livers of such patients.
It seemed important to determine whether hepatocarcinogens could induce
the formation of similar abnormal peptides in rat liver. Although work on this
aspect is not yet complete it has been found that injection of hepatocarcinogens
into rats increases the levels of certain ninhydrin-positive materials in the liver.
Firstly, it was established qualitatively by paper chromatographic and
electrophoretic investigations of phosphate or ethanol extracts of rat liver that
intraperitoneal injections of hepatocarcinogens caused a marked increase in the
level of "free " phosphoethanolamine (PE) in this tissue. In general, a strong
hepatocarcinogenii evoked and maintained a higher level of PE for a longer time
than did a weaker one.
Secondly, it was found that the livers of rats injected with hepatocarcinogens
contained one or two unidentified ninhydrin-positive substances X and Y which
migrated towards the anode during paper electrophoresis at pH 8.6. Spot X was
observed regularly after the application of a strong hepatocarcinogen and its
intensity seemed to run parallel with the intensity of PE. Y was not always
present when X occurred but it often appeared when X was rather intense.
Traces of X but not of Y have been noted occasionally in extracts of normal
rat liver. The nature of X and Y has not yet been completely elucidated but
there is evidence that these substances are acidic peptides and that X at least
seems to be closely related to glutathione.
In the present paper we shall discuss in detail the effect of hepatocarcinogens
onI the content of free PE in rat livers. In a future publication the occurrence
and nature of the peptide-like materials X and Y will be considered in relation
to similar substances which have been found in the livers of tumour-bearing rats
and in tumour extracts.W. J. P. NEISH AND ANN RYLETT
EXPERIMENTAL
Adult male albino rats received single intraperitoneal injections of the azo
dyes 3'-methyl-, 4'-methyl-, 2-methyl- and 4'-ethyl-4-dimethylaminoazobenzene
at dose levels corresponding on a mole for mole basis with a standard injection
of 16.5 mg. of 3'-methyl-4-dimethylaminoazobenzene (3'-MeDAB) in 0.6 ml.
of arachis oil per 100 g. of body weight, as used in earlier work (Neish, 1958,
1959a) on copper metabolism. At this dose level, 2-methyl-4-dimethylamino-
azobenzene (2-MeDAB) proved to be rather toxic and about half of the animals
died within 2 days ofthe injection. Other rats received intraperitoneal injections
of the hepatocarcinogens tannic acid (5 mg./100 g. body weight (b.w.)), dimethyl-
nitrosamine (2-5 mg./100 g. b.w.), DL-ethionine (11.3 mg./100 g. b.w.), and of the
supposedly non-carcinogenic carbon tetrachloride (50 mg./100 g. b.w.) suspended
or dissolved in arachis oil (0-6 ml./100 g. b.w.). Control rats received injections
of arachis oil only (0.6 ml./100 g. b.w.).
At intervals after injections, control and experimental animals were killed
with ether, bled from the heart and the livers perfused via the portal vein with
chilled normal saline. The livers were removed, weighed and stored at once at
-15° C. Not later than 2 hours after perfusion, 2 g. portions of the frozen
livers were homogenized with 4 ml. of full strength Sorensen phosphate buffer
at pH 7.2 in an all-glass homogenizer cooled in ice-water. Supernatants were
obtained by centrifugation of the homogenates for 2 hours at approximately
4500 r.p.m. and 40° F. in an International Portable Refrigerating Centrifuge
Model PR-1. The supernatants were stored at - 15° C. and 0.01 ml. aliquots
were used as required for paper chromatographic and electrophoretic studies.
These extracts seemed to be stable indefinitely if stored at - 15° C.
Alcoholic extracts of livers were prepared by homogenization of 1 g. portions
of the frozen livers with sufficient ice-cold ethanol to give a final supernatant
containing approximately 80 per cent alcohol. In order to assess the amount
of absolute ethanol to be added, liver dry weights were determined by drying
1 g. portions of the livers over sulphuric acid in vacuo at +4° C. to constant
weight. The alcoholic homogenates were centrifuged for 10 minutes at 2000
r.p.m. and 0.01 ml. aliquots of the supernatants were used for paper chromato-
graphic studies.
Two dimensional paper chromatography.-Separations were carried out on 20
cm. squares of Whatman No. 1 paper in the solvent systems (ascending) recom-
mended by Bowden (1959): in the first direction, 80 per cent phenol with an
ammonia atmosphere (sodium cyanide was not included in the tank) and in the
second direction, a mixture of n-butanol (100 ml.), methyl ethyl ketone (100 ml.),
dicyclohexylamine (20 ml.) and water (47 ml.). An aliquot (0-01 ml.) of liver
extract was placed on the paper at a point 3 cm. from adjacent edges.
In early experiments, the papers were stitched with thread in the form of
cylinders which were allowed to stand in 80 ml. of developing solvent in litre
beakers in an enclosed glass tank. Later, a duralumin Datta frame (Bowden,
1959) was used for multiple separations but this proved unsatisfactory in the
phenol run owing to serious contamination of the papers with coloured products
which apparently arose through the action of phenol on the metal frame. A
modified Datta frame which functioned satisfactorily was constructed as follows:
two end pieces, H-shaped, were made ofglass rods ofsuitable length and thickness
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connected with a pair of brass X blocks; at each arm of the H an X block was
placed and 4 narrow glass rods were supported by these X blocks to form a frame.
A dozen chromatography papers (20 x 20 cm.) with corner holes, as supplied
for use with the Datta frame, were placed on the glass frame and separated from
one another by pairs of porcelain penicillin cups. After drying, the papers were
treated with a solution of ninhydrin (0.2 per cent w/v) in n-butanol to 100 ml.
of which was added 4 ml. of glacial acetic acid, dried at room temperature and
heated for 10 minutes at 70° C. Permanent records of ninhydrin-positive spots
were made with auto-positive document paper No. 43.
Phosphate buffer salts did not markedly disturb the separation of pure amino
acid mixtures in this chromatographic system but protein or polypeptide con-
stituents of liver phosphate extracts seemed to interfere with the separation of
substances with high Rf values in phenol. More sharply defined chromatograms
were obtained when alcoholic extracts of liver were used and this method proved
most useful for comparative studies of the PE content of livers.
Paper electrophoresis.-Usually 4 x 0.01 ml. aliquots of liver phosphate ex-
tracts were applied at the mid-line of a strip of Whatman No. 1 paper (12 x 50
cm.) previously moistened with pH 8.6 barbitone buffer (600 ml. of a solution
of sodium barbitone (10.3 g./litre) plus 400 ml. of a solution of barbitone (1.85
g./litre) and blotted. The paper was supported as an inverted V by a glass rod
under the mid-line in a modification of Durrum's apparatus (Durrum, 1950).
The ends of the paper dipped into glass tanks containing 900 ml. of pH 8-6
buffer. Electrical connection was established by KCl-agar bridges (3 per cent
agar agar in saturated KC1) connecting the main buffer compartments to small
glass compartments filled with buffer and provided with carbon electrodes.
Current was supplied by 3 x 120 volt high tension batteries in series. After
3 hours, the paper was removed, dried, and ninhydrin-reacting spots were revealed
by spraying with the ninhydrin-acetic acid mixture mentioned above. The
papers were then dried in an oven at 120° C. until the spot due to aspartic acid
which had initially a distinctive blue colour began to turn reddish (.- 5 minutes).
By this time spots X and Y if present appeared. In earlier work, the papers
were sprayed with a solution of ninhydrin (0.2 per cent w/v) in n-butanol con-
taining no acetic acid. Under these circumstances X and Y usually became
clearly discernible only on the day following spraying and heating.
Further analysis of ninhydrin-positive spots was carried out on sections
cut from electropherograms run simultaneously. Ninhydrin-positive materials
were eluted from the sections with deionized water. The aqueous extracts were
freeze-dried, the residues taken into a small volume of deionized water and the
solutions subjected to two dimensional chromatography as described above.
Satisfactory separations were obtained with apparently little or no interference
from the barbitone components present in the extracts. Likewise mixtures of
amino acids dissolved in barbitone buffer separated well in Bowden's system.
RESULTS
The accompanying figures illustrate the accumulation ofphosphoethanolamine
and of substances X and Y in the livers of rats injected with hepatocarcinogens.
Fig. 1 shows two dimensional chromatograms (cylinder method) of phosphate
extracts of livers from rats injected with (A) arachis oil only, (B) 3'-MeDAB and
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(C) 4'-EtDAB. The livers were obtained 6 days after injection. According to
Miller, Miller and Finger (1957) 3'-MeDAB and 4'-EtDAB are equally potent
carcinogens. Each substance caused about the same degree of accumulation of
PE in rat liver. When synthetic PE was added to the normal liver extract, the
chromatogram showed an increase in the intensity of the rather weak spot due to
naturally occurring PE.
Two dimensional chromatograms (frame method) of phosphate extracts of
livers from rats (A) 3 days and (B) 6 days after carbon tetrachloride injection are
shown in Fig. 2. Areference chromatogram (C) is included to show the separation
of PE from a synthetic mixture of several of the amino acids regularly encoun-
tered in the liver extracts. Note the higher level of PE in the 3-day CC14 liver
EXPLANATION OF PLATES
List of abbreviations for ninhydrin-positive spots:
PE = phosphoethanolamine.
GLU glutamic acid.
GLY glycine.
ASP aspartic acid.
TAU taurine.
G = glutathione.
Vertical and horizontal arrows intersecting at the origin of 2-dimensional chromato-
grams indicate the direction of flow of aqueous phenol and of butanol-methylethylketone-
dicyclohexylamine-water solvents respectively.
FIa. 1. Two-dimensional chromatograms of phosphate extracts of livers from rats 6 days
after intraperitoneal injection of
A arachis oil only.
B- 3'-MeDAB in arachis oil.
C 4'-EtDAB in arachis oil.
FIG. 2.-Two-dimensional chromatograms of phosphate extracts of rat liver.
A-3 days after carbon tetrachloride injection.
B 6 days after carbon tetrachloride injection.
C is a reference chromatogram showing separation of a mixture of the indicated amino
acids from 0 005 ml. of a solution containing 1 mg. of each substance in 5 ml. of phos-
phate buffer pH 7 -2. Each spot equivalent to 1 jg.
Note the double spot due to glutathione.
FIG. 3.-Electropherograms (Whatman No. 1 paper, pH 8- 6 barbitone, 360 volts, 3 hours) of
phosphate extracts of
A rat liver 3 days after tannic acid injection.
B rat liver 3 days after arachis oil injection.
C = 2-dimensional chromatogram of spot 4 from electropherogram A.
D = 2-dimensional chromatogram of spot 4 from electropherogram B.
Electropherograms (as above, 2 hour run) of phosphate extracts of
E- rat liver 6 days after 3'-MeDAB injection.
F -rat liver 6 days after 2-MeDAB injection.
G rat liver 6 days after injection of arachis oil only.
FIG. 4.-Two dimensional chromatograms of ethanolic extracts of rat livers obtained 3 days
after injection of
A arachis oil only.
B -3'-MeDAB.
C 4'-MeDAB.
D - 2-MeDAB.
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as compared with the 6-day CC14 liver. The latter chromatogram (B) is
practically identical with those given by extracts of a 10-day CC14 liver and
of a normal liver. Although carbon tetrachloride is said to be non-carcinogenic
for rat liver, it resembles the feeble carcinogen 4'-MeDAB in that both substancse
have a small capacity for increasing the "free" P.E. content of rat liver 3 days
after injection.
Electrophoretic separations of phosphate extracts of a normal rat liver (B)
and ofthe liver of a rat injected 3 days previously with tannic acid (A) are shown
in Fig. 3. Spots X and Y are present in the tannic acid liver extract but not
in the normal liver. Spots marked 4, 5 and 6 were shown to consist of PE +
glutathione, glutamic and aspartic acids respectively.
Paper strips corresponding to spot 4 for normal and tannic acid liver separa-
tions were cut from 3 parallel separations for each extract and the eluted nin-
hydrin-positive materials were subjected to two-dimensional chromatography.
Fig. 3 (C) shows the marked accumulation of PE in the liver of the rat injected
with tannic acid as compared with the normal rat liver (D). Fig. 3 (E, F and
G) are electropherograms showing the occurrence of X in a rat liver (E) 6 days
after injection with the powerful carcinogen 3'-MeDAB. Spot X is not present
in the liver of a normal rat (G) or in the liver of a rat 6 days after injection ofthe
non-carcinogen 2-MeDAB (F). The nature of ninhydrin-positive spots X and Y
will be discussed in a separate communication.
The use of ethanolic extracts of livers for demonstrating accumulation of
PE due to hepatocarcinogen treatment is shown in Fig. 4. Livers were obtained
3 days after injection from rats which received (A) arachis oil only, (B) 3'-MeDAB
(carcinogenic), (C) 4'-MeDAB (weakly carcinogenic) and (D) 2-MeDAB (non-
carcinogenic). Note the accumulation of PE due to 3'-MeDAB. Studies of
phosphate extracts ofthe same livers revealed that there was a slight accumulation
of PE due to the feebly carcinogenic 4'-MeDAB, 3 days after injection, but only
normal low levels of PE were observed at 6, 10 and 18 days after injection of
this substance (Table I).
In the course of this work it has been found that there is a transient decrease
in the dry weight of rat livers following a single intraperitoneal injection of a
powerful hepatocarcinogen. From the results for five experiments collected in
Table I it is apparent that the degree and persistence of the decrease in liver
dryweight isespecially marked in the livers ofratsinjected with the most powerful
carcinogens, namely 3'-MeDAB, 4'-EtDAB, tannic acid and dimethylnitrosamine.
These results confirm and extend the work of Sauberlich and Baumann (1951)
who noted that the feeding of carcinogenic but not of non-carcinogenic azo dyes
produced a decrease in the dry weight of rat liver. In general, we find that the
elevated levels of PE and the appearance of X parallel this decrease in liver
dry weight percentage. It is of interest to note that after injection of powerful
hepatocarcinogens, there is usually an appreciable diminution in the weight of
the whole liver expressed as a percentage of the total body weight. In Table I
(experiment V) we give these values for the livers of normal rats, for rats treated
with the carcinogenic 3'-MeDAB, and for rats injected with the non-carcinogenic
2-MeDAB. Note the hepatomegaly due to the last mentioned substance.
In Table II are shown the relative PE contents of ethanolic extracts of rat
liver at various times after injection of carcinogenic or non-carcinogenic sub-
stances.
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TABLE I.-Effect of
Substance
injected in
arachis oil
Nil
3'-MeDAB
Various Hepatocarcinogens and Related Substances on the
Dry Weight Percentage ofRat Liver
Time after
injection
(days)
3
6
10
18
Liver dry weight percentage
in experiment No.
I
I
26- 6
26 8
26*3
26 7
22.2
22 7
26 6
26*9
3
6
10
18
II III IV V
26- 1 29 2 30 0 29 1 (4.8)*
25 4 27*5 28*6 27 2 (4-6)
- 26*3 316 -6
23*8
24'1
22 4 (2.9)
- 21 8 (2 6)
4'-MeDAB
2-MeDAB
3
6
10
18
3
6
10
4'-EtDAB
Tannic acid
DL-ethionine
Dimethylnitrosamine
Carbon tetrachloride
3
6
3
6
12
29'0
26 1
27*6 -6
27*4
24 9
27 4
* - ~ 23 7
20-9
- 26 9
-- - 22 9
26 7
3
6
12
3
6
12
3
6
12
29 9
- 27 2
24 3
23 0 25 7
28'1
- 27 4
28 6
-- 32 4
29'1
* Figures in parentheses, liver as percentage of total body weight.
It is interesting that marked accumulation of PE occurred in the case of
DL-ethionine only at the 12th day after injection at which time the decrease in
liver dry weight percentage was most marked.
Although elevations of the level of PE is the most prominent feature in
chromatograms of extracts of carcinogen-treated rat livers, changes in the levels
of other ninhydrin-positive substances do occur. For example, 3 days after
injection ofthe azo dyes (Fig. 4) the following changes were observed:
Substance
injected in
arachis oil
Nil
3'-MeDAB
4'-MeDAB
2-MeDAB
Levels of
PE glutamic acid
++
X . 1-+++ 4_ .4 + + _4-~
28.5 (5 1)
25-9 (5.7)
Glycine
+
I4-
-4
Taurine
+++
1+ lAl
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TABLE II.-Relative PE Contents of Rat Liver at Various Times After Injection
of Carcinogenic or Non-carcinogenic Substances
Level ofphosphoethanolamine
after injection*
Substance (at days)
injected in Carcino- -__
arachis oil genicity 3 6 10-12 18
3'-MeDAB . . -++ +. -
4'-EtDAB . . . + . ++ ++ -
4'-MeDAB . . . + . i
2-MeDAB . . . -
Tannic acid . . + ++ +
Dimethylnitrosamine . + + . + ++ +
DL-ethionine . . + . - - +
Carbon tetrachloride . - - -
Nil . . . _
* When no symbol is shown, no experiment was performed at the stated time. For the assess-
ment of PE spot intensity, scoring was done visually. At least two livers were examined for each
injection time.
Normal livers do in fact contain PE but under our conditions of alcoholic extraction it is barely
detectable chromatographically in the extracts and the level is rate -. Under the influence of
powerful hepatocarcinogens, in spite of the decline in liver dry weight percentage, prominent PE
spots are observed in extracts of these livers. In these instances, the liver PE content evidently
greatly exceeds thenormal levelwhich according to Awapara, Landua andFuerst (1950) is ofthe order
of 17 mg./100 g. wet weight ofliver.
As compared with normal liver, elevated levels of PE, glutamic acid and glycine
occurred 3 days after injection of 3'-MeDAB. On the other hand 4'-MeDAB and
2-MeDAB did not alter the levels of these substances, but the taurine content
of the livers was appreciably reduced. This suggests that cysteine which is
probably the precursor oftaurine is being utilized in some detoxication reaction.
At 6 days after injection of 3'-MeDAB, the liver had an elevated level of PE and
of glutamic acid as compared with a control liver, but the glycine level was
then normal and that oftaurine much reduced. At later times the glutamic acid
level of 3'-MeDAB livers returned to normal.
DISCUSSION
The accumulation of PE in the livers of rats injected with hepatocarcinogens
cannot yet be explained. Perhaps it is due to breakdown of phosphatidyl-
ethanolamine (cephalin) which might accompany the loss of dry matter in rat
liver exposed to hepatocarcinogens or it might be the consequence of an impair-
ment in cephalin synthesis. The first possibility seems unlikely because there
is no evidence yet that enzymes capable of liberating PE from phosphatidyl-
ethanolamine are present in mammalian tissues. With regard to the second
possibility, Kennedy and Weiss (1956) showed that cytidine triphosphate reacts
with PE in the presence of a transferase to yield the nucleotide cytidine di-
phosphate ethanolamine which in turn under the influence of another enzyme
combines with a lipid acceptor to form phosphatidylethanolamine. In the
absence of cytidine triphosphate, PE might accumulate. The observation by
Reid and Lotz (1958) that there is a marked accumulation ofuridine-5'-phosphate
in the livers of rats fed 3'-MeDAB seems to suggest that pathways from uridine
to cytidine triphosphate might indeed be blocked by the hepatocarcinogen.
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Another possible explanation for PE accumulation may be found in the
suppression ofliver alkaline phosphatase activity by hepatocarcinogens. Accord-
ing to McCance, Morrison and Dent (1955) and to Fraser, Yendt and Christie
(1955) patients with hypophosphatasia excrete PE in their urine. This is attri-
buted not to renal malfunction but to a lowered serum alkaline phosphatase
activity resulting in accumulation and excretion of PE. According to McCance
et al. (1955), PE can act as a substrate for alkaline phosphatase. Sachs, Baumer
and Menkhaus (1959) found by histochemical methods that oral administration
of the hepatocarcinogen thioacetamide to rats does indeed lead to a decrease in
liver alkaline phosphatase and Tsuboi and Stowell (1951) observed a decline
in the alkaline phosphatase activity of mouse liver following a single feeding of
carbon tetrachloride (carcinogenic for mouse liver). Woodard (1943), however,
found a marked elevation of alkaline phosphatase in the precancerous livers of
rats fed 4-dimethylaminoazobenzene.
Since serine is a probable precursor of ethanolamine and PE it was unfortunate
that in the present study certain limitations of the chromatographic technique
prevented us from following easily the fate of serine and ethanolamine in rat
liver subjected to the action of hepatocarcinogens. It is hoped to complete this
aspect of the work. Meanwhile it may be noted that Levy, Montanez and Dunn
(1955) reported a decrease in the serine level in rat liver after a single massive
intraperitoneal injection of the hepatocarcinogen, DL-ethionine.
Kensler, Bierman and Condouris (1955) reported that the addition of ethanal-
amine to a diet containing 4-dimethylaminoazobenzene afforded marked protec-
tion to rats against hepatocarcinogenesis. In view of our findings it would seem
that ethanolamine supplements can overcome some deleterious action ofa hepato-
carcinogen which is expressed in the accumulation of PE in the liver.
In certain other aspects of liver cancer, peculiarities in ethanolamine meta-
bolism have been noted. Thus Reid, Landefetd and Simpson (1952) have shown
that the ethanolamine moiety of the choline of rat liver tumours is apparently
synthesized in a different way from that of normal rat liver. Dent, Fowler
and Walshe (1951) have observed the excretion oflarge amounts of ethanolamine
by a patient with primary hepatoma. This metabolic defect was considered to
be either cause or consequence of the hepatoma.
It is of interest to recall the statement by Haven and Bloor (1956) that "ab-
normalities in the metabolism ofethanolamine ifestablished as directly concerned
in carcinogenesis by azo dyes would implicate phospholipids in the induction of
hepatoma." Because of the close correlation which has been observed between
the hepatocarcinogenic potency of a substance and its ability to cause accumula-
tion ofPE in rat liver, a more detailed biochemical study certainly seems warranted
of the metabolism of phospholipids, serine, ethanolamine and PE in the stages
ofhepatocarcinogensis.
SUMMARY
Single intraperitoneal injections of powerful hepatocarcinogens into male
albino rats caused a marked accumulation of phosphoethanolamine in the livers
and the appearance of an unknown ninhydrin-positive substance having the
properties of an acidic thiol peptide.
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ADDENDUM
Since writing this our attention has been directed to several references which
may have a bearing on our investigations.
(a) Ferrari and Tenconi (1957) stated that the livers of normal and adrenalec-
tomized rats which had been injected repeatedly with 10per cent ethanol contained
respectively 8-0 and 23-6 mg. offree PE per 100 g. offresh tissue.
(b) An increase in the free PE content ofthe livers ofrats subjected to adrenal-
ectomy had also been noted by Awapara, Skellenger and Manz (1955).
(c) Spicer and Weise (1956) observed an elevation ofPE in the livers ofrabbits
and guinea-pigs which had been exposed to X-irradiation.
With regard to (a) and (b) it may be noted that DaVanzo and Eversole (1958)
and Symeonidis, Mulay and Burgoyne (1954) found that total adrenalectomy
protects rats against azo dye carcinogenesis. Perhaps the transient rise in liver
PE following injection of an hepatocarcinogen is to be explained by some tem-
porary deleterious action of the carcinogen on the adrenals.
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